Organ-on-Chip Market Set to Reach US$631.1 Million by 2029 Amid Rising Demand for Animal-Free Drug Testing
The global organ-on-chip market is witnessing remarkable growth as pharmaceutical and biotechnology companies increasingly adopt advanced alternatives to traditional animal testing models. Valued at US$89.2 million in 2023, the market expanded to US$123.3 million in 2024 and is projected to grow at an impressive CAGR of 38.6% from 2024 to 2029, ultimately reaching US$631.1 million by 2029. The...
0 Comments 0 Shares 84 Views 0 Reviews
Sponsored